ImmunityBio (NASDAQ:IBRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by research analysts at HC Wainwright in ...

The Dow Jones and S&P 500 posted robust gains Friday afternoon. Nvidia led the Dow and Ulta topped the S&P 500 on the stock ...

Roth Capital issued their Q1 2025 earnings estimates for Fortress Biotech in a research report issued on Tuesday, March 11th. Roth Capital analyst J. Wittes forecasts that the biopharmaceutical ...

We recently compiled a list of the 10 Stocks With At Least $30 Million In Insider Spending Recently. In this article, we are ...

Revenue reached $105 million, outpacing the $99.5 million forecast. In response, PAR Technology's stock surged 13.26% in pre-market trading, reflecting investor enthusiasm. According to ...

Shares of iBio Inc. IBIO shed 3.34% to $3.76 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index COMP rising 0.26% to 19,075. ...

Shares of iBio Inc. IBIO climbed 13.08% to $3.89 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average DJIA rising 0.37% to ...

SAN DIEGO, Feb. 19, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO), an AI-driven innovator of precision antibody therapies, today announced that iBio's common stock has been approved for listing on ...

today announced that iBio’s common stock has been approved for listing on the Nasdaq Capital Market and iBio will transfer its stock exchange listing to Nasdaq Capital Market from the NYSE American.